TickerTalks
Browse all tickers →
TickerTalks›$CI
CICI

Cigna Corporation

$CI·$74B·Medical - Healthcare Plans·Healthcare
$282.52+0.4%YTD+1.7%1Y-5.6%
Mentions · last 7 days
2026-07-13: 211 posts2026-07-14: 63 posts2026-07-15: 59 posts2026-07-16: 41 posts2026-07-17: 4 posts2026-07-18: 3 posts2026-07-19: 0 posts391-5%
Price updated 5m ago·X counts updated 15h ago
CICI
$CICigna Corporation
$282.52+0.38%391 posts-5%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Top X posts

Today's AI verdict on what's driving $CI, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Proven numbersEvent coming upAI verdict · as of 2026-07-20

A known event soon (earnings, a ruling, etc.) will likely decide the next move.

Cigna prints Wednesday at 55% of range — 12x P/E on a healthcare insurer growing 4-10% into a group re-rate.

Cigna Corporation is one of the largest US healthcare-benefits providers — commercial health insurance, pharmacy-benefits management (Express Scripts), and specialty services. The stock is up 1.7% YTD to $281.45, sits at 55% of the 52-week range, and Q2 earnings hits Wednesday July 30 into the broader health-insurer group re-rate.

  • The business is running at solid scale: revenue $68.5B last quarter (+4.6% YoY) and $72.5B the prior quarter (+10.4% YoY), operating margin 3.4%, gross margin 9% — these are commodity-insurance margins, but the free-cash-flow yield sits at 10% which supports the multiple.
  • The valuation is genuinely cheap: PE 12x TTM, 0.28x sales, 8.4x EV/EBITDA — this is 'the market thinks nothing works here' pricing on a business generating 15% ROE, and the multiple has room to expand alongside the health-insurer group.
  • The health-insurer group has been re-rating: UNH, CNC, HUM, MOH all showing signs of the multi-year turnaround landing after the 2024 MCR-shock, and CI is one of the specific laggards that hasn't fully participated yet.
  • Position at 55% of the 52-week range, -2% vs. the 50-day, with no insider transactions on file — quiet institutional ownership coming into the print, no signal of imminent cluster of selling or buying.

Wednesday's Q2 print has to show: revenue growth (needs to hold near 5%), medical-cost-ratio trajectory (must stay stable or improve), Express Scripts PBM growth, and any FY26 EPS guide update. A clean beat with a stable MCR unlocks the trend past $310 as the group re-rate extends. A soft print with MCR surprise (higher medical costs) sends the stock back to $250 where the pre-cycle multiple would look. The 10% FCF yield is the value case; Wednesday decides if the group tailwind lifts CI.

What to watch: Wednesday July 30 Q2 earnings — revenue growth (must hold near 5%), medical-cost ratio (must stay stable or improve), Express Scripts PBM growth trajectory, and FY26 EPS guide update. Also watch the whole health-insurer group (UNH, CNC, HUM). A clean beat with stable MCR unlocks $310+; a soft print sends the stock to $250.

On the calendar: 2026-07-30 — Q2 2026 earnings

health insurer group reratecheap multiplehigh fcf yield

Read the AI verdict + X sentiment for $CI

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Large health insurer and pharmacy-benefits manager operating Evernorth (PBM/care) and Cigna Healthcare segments.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Healthcare Plans sits in its cycle right now — and what that implies for $CI.

Medical - Healthcare Plans · Healthcare

No material change from last week — Oscar Health's AI-driven clinical platform is gaining member growth while the UNH Medicaid fraud litigation adds regulatory risk to legacy insurers.

What this means for $CI

Partial — Large health insurer and pharmacy-benefits manager operating Evernorth (PBM/care) and Cigna Healthcare segments; partial earnings exposure to medical - healthcare plans demand dynamics through its product portfolio.

Top industry ETF

$IHFiShares U.S. Healthcare Providers ETF
+17.9%YTD
+29.8%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
12.1How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
7.6%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
3.4%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
10.0%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
0.3Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
15.2%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
9.3%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.7Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q1 2026Apr 30, 2026$7.79$7.60+2.5%
Q4 2025Feb 5, 2026$8.08$7.88+2.5%
Q3 2025Oct 30, 2025$7.83$7.64+2.5%
Q2 2025Jul 31, 2025$7.20$7.16+0.6%
Next earningsThu, Jul 30·consensus EPS $7.58

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$68.5B+4.6%9.4%3.4%$6.30$864.0M
Q4 FY25$72.5B+10.4%7.7%3.0%$4.64$5.8B
Q3 FY25$69.7B+9.5%8.5%3.7%$7.02$3.1B
Q2 FY25$67.2B+11.1%11.7%3.6%$5.76$-2.2B

Forward consensus

5-year forecast · up to 12 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$284.8B$279.7B – $289.8B$30.46$30.29 – $30.6511
FY27$297.1B$290.8B – $305.5B$33.46$32.47 – $34.1712
FY28$313.4B$312.9B – $314.0B$36.98$29.81 – $44.2010
FY29$320.7B$312.9B – $328.2B$42.00$40.68 – $43.285
FY30$335.9B$327.7B – $343.8B$46.32$44.86 – $47.735

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.1.9×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.55%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-1.8%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+0.3%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatHigh float · 263.2M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today1.2% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.305-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

SellJun 12Jamie G KatesChief Accounting Officer899 sh$268KSellMay 12David CordaniCEO182.3K sh$53.3M
+ 19 other (14 awards · 3 exempts · 2 inkinds) in window

See when $CI insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

3New insider — initial holdingsJul 93
AI summary

Initial Form 3 ownership statement filed by Bryan Holgerson, a newly reportable officer or director at The Cigna Group, disclosing initial beneficial ownership of company securities upon becoming a Section 16 reporting person effective July 1, 2026. Routine Section 16(a) disclosure triggered by appointment or election to a qualifying officer or director role. No operational implications for the company.

3New insider — initial holdingsJul 93
AI summary

Initial Form 3 ownership statement filed by Adam Kautzner, a newly reportable officer or director at The Cigna Group, disclosing initial beneficial ownership of company securities upon becoming a Section 16 reporting person effective July 1, 2026. Routine Section 16(a) disclosure triggered by appointment or election to a qualifying officer or director role. No operational implications for the company.

3New insider — initial holdingsJul 93
AI summary

Initial Form 3 ownership statement filed by Jason Sadler, a newly reportable officer or director at The Cigna Group, disclosing initial beneficial ownership of company securities upon becoming a Section 16 reporting person effective July 1, 2026. Routine Section 16(a) disclosure triggered by appointment or election to a qualifying officer or director role. No operational implications for the company.

3New insider — initial holdingsJul 93
AI summary

Initial Form 3 ownership statement filed by Paul Sanford, a newly reportable officer or director at The Cigna Group, disclosing initial beneficial ownership of company securities upon becoming a Section 16 reporting person effective July 1, 2026. Routine Section 16(a) disclosure triggered by appointment or election to a qualifying officer or director role. No operational implications for the company.

3New insider — initial holdingsJul 93
AI summary

Initial Form 3 ownership statement filed by Matthew Perlberg, a newly reportable officer or director at The Cigna Group, disclosing initial beneficial ownership of company securities upon becoming a Section 16 reporting person effective July 1, 2026. Routine Section 16(a) disclosure triggered by appointment or election to a qualifying officer or director role. No operational implications for the company.

8-KPress release / Reg FDMay 138-K — Item 7.01: Press release / Reg FD
AI summary

CI (CI) disclosed a dividend declaration or distribution announcement under 8-K Item 7.01. The dividend is $30.35 per share. Dividend announcements are material events that directly impact shareholder returns and signal management's view of the company's financial health and cash flow sustainability. Investors monitor dividend continuity and growth as indicators of long-term financial strength.

8-KShareholder voteApr 278-K — Item 5.07: Shareholder vote
AI summary

CI (CI) disclosed the results of its annual meeting of shareholders in an 8-K filing under Item 5.07. Shareholders voted on an advisory say-on-pay resolution, ratification of the independent auditor, shareholder proposals. All management-sponsored proposals were approved by majority shareholder vote. Annual meeting results are a routine disclosure that confirms shareholder ratification of the board's composition and compensation practices.

3New insider — initial holdingsApr 33
+ 13 other (3 13Gs · 2 earnings 8-Ks · 2 proxys · 2 8-Ks) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Angeles Wealth Management LLC Sells 4,145 Shares of Cigna Group $CIdefenseworld.net·2d ago5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (July 2026)seekingalpha.com·9d agoHere's Why Cigna (CI) is a Strong Value Stockzacks.com·13d agoThe Cigna Group's Second Quarter 2026 Earnings Release Detailsprnewswire.com·13d agoCigna Brings AI to Specialty Pharmacy With Pharmacy Forwardzacks.com·18d ago

In themes

Explore the broader themes this ticker is being talked about under.

Trending on X

More in Medical - Healthcare Plans

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$UNH$CVS$OSCR$CNC$ELV$CLOV$MOH
Voices on X · top 1 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport